In the current study, we aimed to investigate possible associations between gut related inflammatory biomarkers including LBP, CD14, TLR4, I-FABP and IL-18 and the presence of CAD and with established CHD, in patients with long-term type 1 diabetes compared to a control group. The gene discussed is FABP2; the disease is coronary artery disorder.